ArticleJournal of the Endocrine Society2026
Sex differences in glucose-regulating neurohormonal pathways-potential impact for type 2 diabetes development.
Article in Journal of the Endocrine Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: Men have a higher risk to develop type 2 diabetes (T2D) than women. The aim of this study was to investigate if there are sex differences in counter-regulatory hormone dynamics that might affect insulin resistance and hence propensity for T2D. Further, we addressed the roles of sex hormones, menopausal status and metabolic phenotypes for such sex differences. Methods: 22 men (7 T2D, BMI 28.8 kg/m Results: Men vs women had higher responses of glucagon, ACTH, cortisol and GH but attenuated HRV responses during hypoglycemia and higher ACTH, more sympathetic dominance and lower GH levels during normo- and hyperglycemia. Post- vs premenopausal women had lower GH levels and less favorable HRV profiles but did not otherwise differ. Within-sex correlations between neurohormonal responses and sex hormones were generally weak. In multilinear regressions, M-value and waist-to-hip ratio were the strongest predictors of cortisol, ACTH and GH responses, whereas sex hormones did not explain within- or between-sex variations in neurohormonal responses. Conclusion: In healthy individuals as well as those with obesity or T2D, glucose-dependent counter-regulatory hormonal responses are elevated in men vs both pre- and postmenopausal women. This may contribute to insulin resistance and hence an increased risk of T2D development in men. Central adiposity, but not sex hormone profiles, may partly explain the observed sex differences.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.